Access Statistics for Christopher James Sampson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Framework for Value-aligned Pricing of Combination Therapies 0 0 3 5 2 4 8 14
Barriers to Uptake of Minimal Access Surgery in the United Kingdom 0 0 1 2 2 8 12 20
Cost implications of treatment non-completion in a forensic personality disorder service 0 0 0 15 1 7 9 51
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? 0 0 1 9 1 5 10 34
Happy and healthy: a joint model of health and life satisfaction 0 0 0 87 0 8 10 295
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy 0 0 2 29 0 10 18 107
How is Quality of Life Measured for Health Technology Assessments? 0 0 2 16 3 9 13 51
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C 0 0 1 1 2 6 7 11
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe 0 0 4 7 0 4 12 21
The Impact of New Medicines in the NHS: 70 Years of Innovation 0 0 0 1 0 1 6 12
The relationship between individual risk and cost-effectiveness in screening interventions 0 0 1 43 0 6 10 298
Total Working Papers 0 0 15 215 11 68 115 914
4 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 0 0 0 3 4 9 17 94
Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al 0 0 0 1 1 5 7 13
Is anchoring at ‘dead’ a theoretical requirement for health state valuation? 0 0 0 1 1 7 7 13
Marginal cost per QALY estimates: What are they good for? 1 1 3 11 4 13 25 59
Model Registration: A Call to Action 0 0 0 4 0 5 7 68
NICE and the EQ-5D-5L: Ten Years Trouble 0 1 1 4 1 3 7 23
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy 2 4 21 28 5 21 86 144
Transparency in Decision Modelling: What, Why, Who and How? 0 0 0 4 3 6 14 65
Total Journal Articles 3 6 25 56 19 69 170 479


Statistics updated 2026-03-04